Zinc Deficiency Promoted Fibrosis via ROS and TIMP/MMPs in the Myocardium of Mice

Biological Trace Element Research volume 196, pages145–152(2020)Cite this article

Abstract

Zinc (Zn) is an important trace element in the body that has antioxidant effects. It has been proven that Zn deficiency can cause oxidative stress. The purpose of the present study was to clarify the effect and mechanism of Zn deficiency on myocardial fibrosis. Mice were fed with different Zn levels dietary for 9 weeks: Zn-normal group (ZnN, 34 mg Zn/kg), Zn-deficient group (ZnD, 2 mg Zn/kg), and Zn-adequate group (ZnA, 100 mg Zn/kg). We found that the Zn-deficient diet reduced the Zn concentration in myocardial tissue. Moreover, the TUNEL results demonstrated that cardiomyocytes in the ZnD group died in large numbers. Furthermore, ROS levels were significantly increased, and metallothionein (MT) expression levels decreased in the ZnD group. The results of Sirius Red staining indicated an increase in collagen in the ZnD group. Moreover, the ELISA results showed that collagen I, III, and IV and fibronectin (FN) were increased. In addition, the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) was detected by RT-qPCR. The results showed that the expression of TIMP-1 in the ZnD group was increased, while MMPs were decreased. Immunohistochemical results showed an increase in the content of α-smooth muscle actin (α-SMA), while H&E staining showed an increase in interstitial width and a decrease in the number of cardiac cells. All data suggest that Zn deficiency enhances the oxidative stress response of myocardial tissue and eventually triggers myocardial fibrosis.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. 1.

    Writing C, Smith SC Jr, Collins A, Ferrari R, Holmes DR Jr, Logstrup S et al (2012) Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Glob Heart 7:297–305

    Article  Google Scholar 

  2. 2.

    Gyongyosi M, Winkler J, Ramos I, Do QT, Firat H, McDonald K et al (2017) Myocardial fibrosis: biomedical research from bench to bedside. Eur J Heart Fail 19:177–191

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC (2013) Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10:15–26

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35:569–582

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Gonzalez A, Ravassa S, Beaumont J, Lopez B, Diez J (2011) New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 58:1833–1843

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Zhao S, Wu H, Xia W, Chen X, Zhu S, Zhang S, Shao Y, Ma W, Yang D, Zhang J (2014) Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J Cardiol 63:373–378

    Article  PubMed  Google Scholar 

  7. 7.

    Li AH, Liu PP, Villarreal FJ, Garcia RA (2014) Dynamic changes in myocardial matrix and relevance to disease: translational perspectives. Circ Res 114:916–927

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Xiang FL, Fang M, Yutzey KE (2017) Loss of beta-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice. Nat Commun 8:712

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Zebrowski DC, Engel FB (2013) The cardiomyocyte cell cycle in hypertrophy, tissue homeostasis, and regeneration. Rev Physiol Biochem Pharmacol 165:67–96

    Article  PubMed  Google Scholar 

  10. 10.

    Kuhn B, del Monte F, Hajjar RJ, Chang YS, Lebeche D, Arab S et al (2007) Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 13:962–969

    Article  CAS  PubMed  Google Scholar 

  11. 11.

    Shamhart PE, Meszaros JG (2010) Non-fibrillar collagens: key mediators of post-infarction cardiac remodeling? J Mol Cell Cardiol 48:530–537

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562–573

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Scrimgeour AG, Carrigan CT, Condlin ML, Urso ML, van den Berg RM, van Helden HPM, Montain SJ, Joosen MJA (2018) Dietary zinc modulates matrix metalloproteinases in traumatic brain injury. J Neurotrauma 35:2495–2506

    Article  PubMed  Google Scholar 

  15. 15.

    Yoshida A, Kanamori H, Naruse G, Minatoguchi S, Iwasa M, Yamada Y, Mikami A, Kawasaki M, Nishigaki K, Minatoguchi S (2019) (Pro)renin receptor blockade ameliorates heart failure caused by chronic kidney disease. J Card Fail 25:286–300

    Article  PubMed  Google Scholar 

  16. 16.

    Jarosz M, Olbert M, Wyszogrodzka G, Mlyniec K, Librowski T (2017) Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-kappaB signaling. Inflammopharmacology 25:11–24

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Vasak M, Meloni G (2011) Chemistry and biology of mammalian metallothioneins. J Biol Inorganic Chem : JBIC : a publication of the Society of Biological Inorganic Chemistry 16:1067–1078

    CAS  Article  Google Scholar 

  18. 18.

    Ji SG, Weiss JH (2018) Zn2+-induced disruption of neuronal mitochondrial function: synergism with Ca2+, critical dependence upon cytosolic Zn2+ buffering, and contributions to neuronal injury. Exp Neurol 302:181–195

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Castro L, Freeman B (2001) Reactive oxygen species in human health and disease. Nutrition 17:161–165

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Lorenzen JM, Schauerte C, Hubner A, Kolling M, Martino F, Scherf K et al (2015) Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis. Eur Heart J 36:2184–2196

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Xiang FL, Guo MZ, Yutzey KE (2016) Overexpression of Tbx20 in adult cardiomyocytes promotes proliferation and improves cardiac function after myocardial infarction. Circulation 133:1081–1092

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Tomat AL, Costa MD, Arranz CT (2011) Zinc restriction during different periods of life: influence in renal and cardiovascular diseases. Nutrition 27:392–398

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Maret W (2000) The function of zinc metallothionein: a link between cellular zinc and redox state. J Nutr 130:1455s–1458s

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Oliveira HCF, Cosso RG, Alberici LC, Maciel EN, Salerno AG, Dorighello GG et al (2004) Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J 18:278

    Google Scholar 

  25. 25.

    Sato M, Kondoh M (2002) Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med 196:9–22

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Yang LF, Ma JP, Tan Y, Zheng QJ, Dong ML, Guo W et al (2019) Cardiac-specific overexpression of metallothionein attenuates L-NAME-induced myocardial contractile anomalies and apoptosis. J Cell Mol Med 23:4640–4652

    CAS  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Laity JH, Andrews GK (2007) Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1). Arch Biochem Biophys 463:201–210

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Prasad AS (2008) Zinc in human health: effect of zinc on immune cells. Mol Med 14:353–357

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Frangogiannis NG (2019) Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Asp Med 65:70–99

    CAS  Article  Google Scholar 

  30. 30.

    Li L, Zhao Q, Kong W (2018) Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol 68-69:490–506

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Malemud CJ (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci-Landmrk 11:1696–1701

    CAS  Article  Google Scholar 

  32. 32.

    Peterson JT, Li H, Dillon L, Bryant JW (2000) Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 46:307–315

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Lovelock JD, Baker AH, Gao F, Dong JF, Bergeron AL, McPheat W, Sivasubramanian N, Mann DL (2005) Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts. Am J Physiol-Heart C 288:H461–H468

    CAS  Article  Google Scholar 

  34. 34.

    Karamanos NK, Theocharis AD, Neill T, Iozzo RV (2019) Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases. Matrix Biol 75-76:1–11

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Barbolina MV, Stack MS (2008) Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. Semin Cell Dev Biol 19:24–33

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Moore L, Fan D, Basu R, Kandalam V, Kassiri Z (2012) Tissue inhibitor of metalloproteinases (TIMPs) in heart failure. Heart Fail Rev 17:693–706

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG et al (2001) Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104:826–831

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People’s Republic of China

    Jing-wen Cao, Shi-yu Duan, Hong-xin Zhang, Yu Chen & Mengyao Guo

Authors
  1. Jing-wen Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shi-yu Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hong-xin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mengyao Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mengyao Guo.

Ethics declarations

All animals were obtained from Huazhong Agricultural University Laboratory Animal Research Center (Wuhan, China), according to the animal welfare standards of use, and approved by the Ethical Committee on Animal Research at Huazhong Agricultural University (HZAUMO-2015-12).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cao, Jw., Duan, Sy., Zhang, Hx. et al. Zinc Deficiency Promoted Fibrosis via ROS and TIMP/MMPs in the Myocardium of Mice. Biol Trace Elem Res 196, 145–152 (2020). https://doi.org/10.1007/s12011-019-01902-4

Download citation

Keywords

  • Zn deficiency
  • Myocardial fibrosis
  • Oxygen radicals (ROS)
  • Matrix metalloproteinases (MMPs)
  • Extracellular matrix (ECM)